Oral anticoagulants for stroke prevention in nonvalvular AF
End of embargo2018-09-27
MetadataView full catalogue record
KeywordsWarfarinDirect oral anticoagulants (DOACs)Stroke preventionAtrial fibrillationBarriersInitiation
Permissions© 2018 Wiley. This is the accepted manuscript version of the article above which has been published in final form at https://doi.org/10.1002/psb.1611. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Warfarin and direct oral anticoagulants (DOACs) have been shown to reduce the risk of stroke in patients with atrial fibrillation, yet many patients are still not being anticoagulated. This article discusses the barriers to the initiation of oral anticoagulants, in particular DOACs, and how these can be overcome.